Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich s Revenues, Earnings Increase in Q2

NEW YORK, July 23 (GenomeWeb News) - Sigma-Aldrich yesterday reported increased revenues and earnings for the second quarter.

 

Revenues were $348.6 million, up from $327 million during the same quarter last year.

 

Research and development costs stayed flat at $10.2 million, compared to $10.5 million during the same period in 2003.

 

Sigma's net income for the quarter was $59.6 million, or $.85 per share, up from $48.1 million, or $.67 per share, during the second quarter last year.

 

As of June 30, Sigma-Aldrich had $138.7 million in cash and cash equivalents.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.